Yale University Scholl of Medicine
Welcome,         Profile    Billing    Logout  
 1 Trial 
1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Antin-Ozerkis, Danielle
STOP-IPF, NCT04598919: Saracatinib in the Treatment of Idiopathic Pulmonary Fibrosis

Active, not recruiting
1/2
49
US
Saracatinab, Placebo
National Jewish Health, Yale University, Icahn School of Medicine at Mount Sinai, AstraZeneca, National Center for Advancing Translational Sciences (NCATS), Baylor University, International Center for Health Outcomes and Innovation Research
Idiopathic Pulmonary Fibrosis (IPF)
09/24
06/25

Download Options